Overview BHV-7000 Acute Treatment of Bipolar Mania Status: COMPLETED Trial end date: 2025-01-30 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether BHV-7000 is a safe and effective acute treatment for manic episodes in bipolar disorder I.Phase: PHASE2 Details Lead Sponsor: Biohaven Therapeutics Ltd.